Thomas C. Varvaro is Director at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX). They have made 5 open-market trades across 2 companies since 2011, most recently 2018-04-03.
CIK 0001437495
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $6K since 2011, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBVX | SELL | 2018-01-23 | 2018-01-24 | $0.85 | $30K | -14.8% | -16.5% | -48.6% |
| CDXC.OB | BUY | 2014-08-25 | 2014-08-25 | $1.09 | $2K | N/A | N/A | N/A |
| CDXC.OB | BUY | 2014-08-22 | 2014-08-22 | $1.20 | $2K | N/A | N/A | N/A |
| CDXC.OB | BUY | 2011-12-09 | 2011-12-13 | $0.65 | $1K | N/A | N/A | N/A |
| CDXC.OB | BUY | 2011-12-07 | 2011-12-08 | $0.63 | $945 | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.